Compare Cardinal Health Inc (CAH) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Occidental Petroleum Corporation — how do they compare? Cardinal Health Inc trades at $237.44 (market cap $55.88B), while Occidental Petroleum Corporation trades at $58.72 (market cap $55.89B). The key difference: Cardinal Health Inc and Occidental Petroleum Corporation are close in size by market cap, and Occidental Petroleum Corporation pays the higher dividend (2%). Which is the better fit depends on your goals.
| CAH | OXY | |
|---|---|---|
Market Cap | $55.88B | $55.89B |
Sector | Health | Energy |
52-Week High | $240.26 | $66.24 |
52-Week Low | $146.04 | $38.92 |
Enterprise Value | $59.91B | $74.65B |
Dividend Yield | 0.86% | 2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $237.18, up 0.33% on the day, near its 52-week high. The stock shows bullish technical signals with consistent earnings beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%. Positive sentiment is driven by strong Q4 2026 results and optimistic fiscal 2027 guidance highlighted by Reuters on August 11, 2026.
Outlook remains favorable with analyst consensus price target of $266.43 implying 12% upside. Key opportunities include pharmaceutical segment strength and dividend payments, while risks involve high debt levels and thin profit margins. The bullish analyst stance (54.55% buy ratings) supports growth potential, but investors should monitor cash flow volatility and competitive pressures.
Occidental Petroleum (OXY) trades at $58.65, up 4.9% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $2.40, exceeding expectations, and is focusing on debt reduction while targeting over $4 billion in annual sustainable cash flow by 2030. Valuation ratios remain reasonable with a P/E of 16.49 and EV/EBITDA of 5.26.
The outlook is positive, driven by operational outperformance and higher oil prices, but remains sensitive to commodity volatility. Analyst consensus is a Buy with a $69.33 price target, though execution risks and oil price dependence are key considerations for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
